Immunotherapy is a breakthrough in lung cancer treatment
Improves survival among patients with late-stage lung cancer
Strengthens the immune system’s capacity to detect and destroy cancer cells
More manageable and tolerable side effects compared with other therapies
What is it? How does it work?
AN IMPORTANT FACTOR OF PERSONALIZED MEDICINE
Biomarkers are proteins found in blood, tissues, and fluids that help identify the best possible treatment for a patient.
TARGET FOR IMMUNOTHERAPY
Immunotherapy targets the Programmed Death-Ligand 1 (PD-L1) protein expressed in lung tumors.
ENSURING MAXIMUM BENEFIT
Measuring a patient’s PD-L1 biomarker expression can help ensure the best response to immunotherapy.
THE FUTURE OF CANCER TREATMENT